Lung Cancer Trial, Recruiting (NCT04654364)

Lung Cancer Trial, Recruiting NCT04654364 Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04654364 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with non-small cell lung cancer (a type of lung cancer) at an advanced stage (stage III A, B, or C, or stage IV A or B)
You have been diagnosed with small cell lung cancer (another type of lung cancer), whether it is at a limited or extensive stage
You are 18 years old or older

Who may not be able to join:

Because this trial is an observational registry (meaning researchers are recording information rather than testing a new treatment), there are no specific rules that would stop someone from taking part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard Greil, MD, AGMT gemeinnützige GmbH

Phone: +436626404412

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04654364

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: +436626404412

More information: https://clinicaltrials.gov/study/NCT04654364

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with non-small cell lung cancer (a type of lung cancer) at an advanced stage (stage III A, B, or C, or stage IV A or B)
You have been diagnosed with small cell lung cancer (another type of lung cancer), whether it is at a limited or extensive stage
You are 18 years old or older

Who may not be able to join:

Because this trial is an observational registry (meaning researchers are recording information rather than testing a new treatment), there are no specific rules that would stop someone from taking part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Registry

ClinicalTrials.gov

Start date

18 August 2020

Est. completion

1 August 2030

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

General characteristics; Molecular testing; Characterize subgroups; Treatment duration; Treatment frequency; Degree of treatment response; Treatment sequence; Outcome OS; Outcome PFS; Toxicity of treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov